Find a Lawyer in Your State

Need Help?

Contact Us Today

Call Today: 800-250-7280

I agree that submitting this form and the information contained within does not establish an attorney client relationship.

ATTORNEY ADVERTISING -
Flood Law Group, LLP
1101 Pennsylvania Avenue
Suite 600
Washington, DC 20004
(888) 334-2084

Privacy protected. All information held in the strictest confidence.

Paxil Birth Defects

New studies point to an increased risk of Paxil birth defects in babies whose mothers use the antidepressant during pregnancy. According to the findings of two studies, women who were taking Paxil during their first trimester were one and a half to two times more likely to have a baby with a heart defect than women who were taking other antidepressants or women of the general population. A later study found that women who took Paxil at 20 weeks or later were six times more likely to have a baby with a rare birth defect known as persistent pulmonary hypertension, or PPHN.

Heart Malformations

The heart malformations reported in the two studies ranged from minor to severe defects, some of which required surgery to repair. In most cases, the defects were atrial and ventricular septal defects, which are characterized by holes in the walls of the heart’s chambers.

These defects were most likely to occur in the first trimester. Other complications found in babies whose mothers used Paxil during this time included: breathing problems, seizures, low blood sugar, irritability and tremors.

Paxil and PPHN

In July 2006, the FDA warned of the risk of PPHN in babies when taken later—after the 20 th week—of pregnancy. The FDA’s warning was prompted by a study published several months earlier in the New England Journal of Medicine.

Babies with PPHN become very sick because of abnormal blood flow in the heart and lungs. The inhibited blood flow prevents oxygen from getting to vital organs and may result in multiple organ failure and death.

Even prompt treatment does not guarantee a positive outcome. Some babies still have difficulty getting an adequate oxygen supply to their bodies and those who survive may suffer from lifelong disability.

About Paxil

Paxil was the third SSRI (selective serotonin reuptake inhibitor) to hit the U.S. market for the treatment of depression and other psychiatric disorders. Since its release in 1992, the drug has been the subject of numerous labeling changes—most recently, to reflect the risk of Paxil birth defects but also to highlight the risk of suicidal behavior in children and adults.

Due to the risk of Paxil birth defects, the FDA urged the drug’s maker to change the pregnancy category on the drug from C to D, which means that studies in pregnant women have demonstrated risks to the fetus.

If your baby suffers from a Paxil birth defect, please contact a qualified Paxil attorney who can help protect and maximize your interests.

Defective Drugs Breaking News

"Newest Paxil Lawsuit comes from Canada"

A woman living in Canada filed a defective drug lawsuit against Glaxo Smith Kline, the distributor of Paxil, a drug prescribed to treat depression. According to the lawsuit, Shannon Cote, 29, was prescribed » Read More

"Paxil Showed Significant Increase in Sperm Damage"

A small clinical study reported recently in New Scientist magazine found that men who were taking an antidepressant such as Paxil showed significant increases i...

» Read More